Published in J Pharmacol Exp Ther on June 01, 1968
Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles. Antimicrob Agents Chemother (1976) 2.04
Determination of metronidazole and its two major metabolites in biological fluids by high pressure liquid chromatography. Br J Clin Pharmacol (1978) 2.03
Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose. Br J Clin Pharmacol (1979) 1.76
Uptake of metronidazole and its effect on viability in trichomonads and Entamoeba invadens under anaerobic and aerobic conditions. Antimicrob Agents Chemother (1976) 1.63
Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis. Gut (1982) 1.59
Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin Microbiol Rev (2004) 1.43
Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses. Br J Vener Dis (1975) 1.41
A rapid and specific semi-micro method involving high-pressure liquid chromatography for the assay of metronidazole in plasma, saliva, serum, urine and whole blood. Br J Clin Pharmacol (1980) 1.38
Pharmacokinetics of metronidazole as determined by bioassay. Antimicrob Agents Chemother (1974) 1.21
Metronidazole bioassay. Antimicrob Agents Chemother (1976) 1.11
Liquid chromatographic assay for metronidazole and tinidazole: pharmacokinetic and metabolic studies in human subjects. Antimicrob Agents Chemother (1981) 1.10
In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides spp. Antimicrob Agents Chemother (1994) 0.99
The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst. Drug Metab Dispos (2013) 0.82
Pharmacokinetics of metronidazole in patients with alcoholic liver disease. Antimicrob Agents Chemother (1987) 0.76
Pharmacokinetics of metronidazole in patients with varying degrees of renal failure. Br J Clin Pharmacol (1985) 0.75
Disposition and Residue Depletion of Metronidazole in Pigs and Broilers. Sci Rep (2017) 0.75
Leukopenia and thrombocytopenia secondary to clinoril therapy. Lancet (1980) 1.06
Isolation and identification of the major urinary metabolite of metronidazole. Life Sci (1967) 1.01
Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose. Clin Pharmacol Ther (1978) 0.99
Effect of diphenylhydantoin on glucose tolerance in patients with hypoglycemia. Diabetes (1974) 0.96
Lymphangioma in four dogs. J Am Vet Med Assoc (1978) 0.88
Phase I study of 5-azacytidine (NSC-102816) . Cancer Chemother Rep (1972) 0.88
The clinical pharmacology of meperidine--comparison of routes of administration. J Clin Pharmacol (1976) 0.85
Phase II study of 5-azacytidine in solid tumors. Cancer Treat Rep (1977) 0.84
Influence of age and dietary stress on hexobarbital activity in mice. Proc Soc Exp Biol Med (1967) 0.83
Preliminary pharmacokinetics of streptozotocin, an antineoplastic antibiotic. J Clin Pharmacol (1977) 0.83
Identification of the metabolites of metronidazole in the human vagina. Wiad Parazytol (1969) 0.83
Dose ranging evaluation of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis. J Clin Pharmacol (1985) 0.82
Peritoneal mesothelioma associated with diffuse abdominal ossification and unusual presentation. J Med Soc N J (1977) 0.81
Diffusion in the various zones of the normal and the rachitic growth plate. J Bone Joint Surg Am (1980) 0.81
Absorption, distribution, and excretion of 5-azacytidine (NSC-102816) in man. Cancer Chemother Rep (1972) 0.81
Comparison of intramuscular dezocine with butorphanol and placebo in chronic cancer pain: a method to evaluate analgesia after both single and repeated doses. Clin Pharmacol Ther (1987) 0.80
The characterization of substituted nitroimidazoles on paper and thin layer chromatography by colorimetric reactions. J Chromatogr (1967) 0.80
Phase II trial of vindesine in advanced neoplastic disease. Cancer Treat Rev (1980) 0.80
Analgesic efficacy and pharmacokinetic evaluation of meperidine and hydroxyzine, alone and in combination. Cancer Invest (1983) 0.76
Mutagenicity of metronidazole: structure-activity relationships. Mutat Res (1976) 0.76
A potentially toxic drug interaction between pethidine (meperidine) and phenobarbitone. Lancet (1977) 0.76
A hypothesis concerning the effect of changes in scheduling upon the cardiotoxicity of adriamycin. Oncology (1983) 0.75
GLC determination of meperidinic and normeperidinic acids in urine. J Pharm Sci (1978) 0.75
Therapeutic equivalency of two lidocaine preparations. Am J Hosp Pharm (1976) 0.75
Drug interaction: meperidine and chlorpromazine, a toxic combination. J Clin Pharmacol (1981) 0.75
Ectopic production of ACTH by a primary adenocarcinoma of the colon. J Med Soc N J (1978) 0.75
The bioavailability of meperidine. J Clin Pharmacol (1974) 0.75
The management of the patient with chronic pain due to advanced malignancy. J Med (1982) 0.75
Influence of age and diet on the induction of hexobarbital-metabolizing enzymes in the mouse. Proc Soc Exp Biol Med (1968) 0.75
Analgesic efficacy of zomepirac sodium in patients with pain due to cancer. J Clin Pharmacol (1982) 0.75
Pharmacokinetics and mechanisms of action of analgesics in clinical pain. J Clin Pharmacol (1982) 0.75
Influence of age and diet on the induction of microsomal enzymes in the mouse. Proc Soc Exp Biol Med (1971) 0.75
Response to treatment of systemic cryptococcosis in a patient with advanced malignancy: a case report. Del Med J (1982) 0.75
Newer concepts in pain therapy by applied pharmacology of the analgesics. Del Med J (1981) 0.75
Double-blind comparisons of zomepirac and oxycodone with APC in cancer pain. J Clin Pharmacol (1980) 0.75
Sensitive assay for determination of hydroxyzine in plasma and its human pharmacokinetics. J Pharm Sci (1979) 0.75
The effect of phenobarbital on the metabolism of meperidine in normal volunteers. J Clin Pharmacol (1978) 0.75
The absorption and metabolism of dibromodulcitol in patients with advanced cancer. Clin Pharmacol Ther (1972) 0.75
Fate of streptozotocin (NSC-85998)in patients with advanced cancer. Cancer Chemother Rep (1976) 0.75
Analysis of procarbazine and metabolites by gas chromatography-mass spectrometry. J Chromatogr (1980) 0.75
The bioavailability of meperidine using urine assays for meperidine and normeperidine. J Clin Pharmacol (1975) 0.75
Influence of dietary stress on microsomal enzyme activity in immature mice. Biochem Pharmacol (1968) 0.75